Work

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Year: 2019

Type: article

Study design: Clinical Trial

Source: Gastric Cancer

DOI: 10.1007/s10120-019-00958-4

Authors: Tae-Yong Kim, Hye Sook Han, Keun-Wook Lee, Dae Young Zang, Sun Young Rha, Young Iee Park, Jin-Soo Kim, Kyung-Hun Lee, Se Hoon Park, Eun-Kee Song, Soo-A Jung, NaMi Lee, Yeul Hong Kim, Jae Yong Cho, Yung-Jue Bang

Institutions: Seoul National University, Seoul National University Hospital, Chungbuk National University, Seoul National University Bundang Hospital, Hallym University Sacred Heart Hospital, Yonsei University, Yonsei Cancer Hospital, National Cancer Center, SNUH SMG-SNU Boramae Medical Center, Samsung Medical Center, Sungkyunkwan University, Jeonbuk National University, Hanmi Pharmaceutical (South Korea), Korea University Anam Hospital, Gangnam Severance Hospital

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2929200032

FWCI: 2.359

Cites: 37

Cited by: 37

Related to: 10